Melanocortin Receptor-Mediated Anti-Inflammatory Effect of Acthar® Gel in Human Myeloid Cells
Neuroimmunomodulation · 08.08.2025 · 32 (1) · 213-219
DOI: 10.1159/000547302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroimmunomodulation, online erschienen am 08.08.2025. Verfasst von Kyle Hayes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mallinckrodt Pharmaceuticals, Bridgewater, New Jersey, USA, kyle.hayes@mnk.com. Hauptthemen laut MEDLINE: Adrenocorticotropic Hormone, Anti-Inflammatory Agents, Receptors, Melanocortin, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Acthar® Gel, a complex mixture of porcine adrenocorticotropic hormone analogs that activates all 5 melanocortin receptor (MCR) subtypes, is an approved noncorticosteroid treatment for multiple sclerosis (MS) exacerbations.
Methods
MCR expression and anti-inflammatory effects of Acthar Gel in human monocyte-derived macrophages (MDMs) and human brain-derived microglia were investigated following lipopolysaccharide stimulation in vitro.
Results
MC1R was expressed at substantially higher levels than the other MCR subtypes in human MDMs and was the only MCR gene detected in human adult microglia. As shown by microarray gene expression analysis, polarization of MDMs to a pro-inflammatory phenotype increased the expression and secretion of interleukin-6, tumor necrosis factor α, and CXC motif chemokine ligand 10, which were inhibited in a dose-dependent manner with Acthar Gel treatment.
Conclusions
These results are consistent with previous insights that Acthar Gel has an immunomodulatory mechanism distinct from glucocorticoids alone and suggest that Acthar Gel can improve clinical outcomes in MS and other inflammation-mediated central nervous system disorders by inhibiting multiple pro-inflammatory cytokine signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mallinckrodt Pharmaceuticals, Bridgewater, New Jersey, USA, kyle.hayes@mnk.com.
- Mallinckrodt Pharmaceuticals, Bridgewater, New Jersey, USA.
Zitieren
APA
Hayes, K., & Wright, D. (2025). Melanocortin Receptor-Mediated Anti-Inflammatory Effect of Acthar® Gel in Human Myeloid Cells. Neuroimmunomodulation, 32(1), 213-219. https://doi.org/10.1159/000547302
Vancouver
Hayes K, Wright D. Melanocortin Receptor-Mediated Anti-Inflammatory Effect of Acthar® Gel in Human Myeloid Cells. Neuroimmunomodulation. 2025;32(1):213-219. doi:10.1159/000547302
BibTeX
@article{Hayes2025,
author = {Hayes, Kyle and Wright, Dale},
title = {Melanocortin Receptor-Mediated Anti-Inflammatory Effect of Acthar® Gel in Human Myeloid Cells},
journal = {Neuroimmunomodulation},
year = {2025},
volume = {32},
number = {1},
pages = {213--219},
doi = {10.1159/000547302}
}
EUVIMED